On its news page, Japanese company Rege Nephro reported that its Chief Scientific Advisor, Professor Kenji Osafune

from Kyoto University’s CiRA, delivered an invited keynote lecture at the “2025 Taiwan Regenerative Medicine Summit”

held at Kaohsiung Medical University on April 10, 2025, presenting the latest advances in iPS cell–based regenerative therapies

and drug discovery for kidney diseases.

Full report：https://www.regenephro.co.jp/en/news/2025-04-23